Hyperfine develops portable MRI systems designed to enable brain imaging at the bedside and in outpatient settings. The company is focused on expanding sales beyond hospital critical care into neurology offices and international markets while continuing to invest in software development and clinical studies to support broader adoption. Hyperfine reported $13.6 million in revenue for 2025, a 5.2% increase year over year, including $5.3 million in fourth-quarter revenue which more than doubled year over year. Despite revenue growth, the company posted a net loss of about $35.6 million for 2025 and ended the year with roughly $35 million in unrestricted cash. Hyperfine reduced its global workforce in January 2025 by about 14% and had 102 employees as of Feb. 15, 2026, down from 111 a year earlier.

Total raised

$134M

Funding rounds

3

Latest round

Debt Financing

Latest activity

Mar 2026